Proteina | Protein-Protein Interactions

Born in groundbreaking research

Proteina was born as a faculty startup in the lab at the Korea Advanced Institute of Science and Technology (KAIST). We recognized early the importance of direct analysis of protein-protein interactions (PPIs), since the product of a gene is inherently more complex and closer to function than the gene itself. This insight led to our development of Proteina’s first-in-class analysis platform that enables quantitative PPI measurement at the single-molecule level. Proteina is located in the Institute of Molecular Biology & Genetics, Seoul National University.

Unique protein expertise

Proteina has accumulated extensive knowledge in developing assays to measure targeted PPIs and analyzing the resulting data. This expertise makes Proteina a uniquely valuable partner, accelerating the process of precision drug discovery and development.

Strong IP portfolio

The unique nature of Proteina’s foundational science and technology is supported by our strong intellectual property estate. This currently includes 32 registered patents in the U.S., Europe (UK, Germany, France, Switzerland), Korea, Japan, and China with 9 additional patents pending.

Proteina is helping biopharmaceutical innovators take the fast lane to new precision medicines.

Learn about our technology platform

Revealing the power of proteins to transform medicine

Born in groundbreaking research

Unique protein expertise

Strong IP portfolio

Proteina is helping biopharmaceutical innovators take the fast lane to new precision medicines.